Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$34.00
-2.0%
$38.23
$11.20
$72.98
$7.55B1.3713.39 million shs21.27 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.73
-1.0%
$26.28
$24.48
$31.54
$145.79B0.6140.13 million shs37.26 million shs
Starbucks Co. stock logo
SBUX
Starbucks
$98.69
-0.9%
$104.63
$71.55
$117.46
$112.10B0.9910.63 million shs9.46 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-1.95%-16.98%-23.94%+12.96%+132.72%
Pfizer Inc. stock logo
PFE
Pfizer
-1.05%-0.78%-0.54%+1.40%-8.16%
Starbucks Co. stock logo
SBUX
Starbucks
-0.89%-11.64%-11.45%+0.89%+6.81%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.4887 of 5 stars
2.12.00.00.03.03.31.9
Pfizer Inc. stock logo
PFE
Pfizer
4.8876 of 5 stars
2.33.04.24.22.83.33.1
Starbucks Co. stock logo
SBUX
Starbucks
4.2517 of 5 stars
2.33.03.31.93.31.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.27
Hold$37.239.50% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.50
Moderate Buy$31.9224.09% Upside
Starbucks Co. stock logo
SBUX
Starbucks
2.59
Moderate Buy$105.757.15% Upside

Current Analyst Ratings Breakdown

Latest HIMS, SBUX, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/6/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderperform ➝ Underperform$21.00 ➝ $21.00
3/6/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell ➝ Sell$27.00 ➝ $27.00
2/26/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$24.00 ➝ $39.00
2/25/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$24.00 ➝ $40.00
2/25/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $35.00
2/25/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$25.00 ➝ $27.00
2/25/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$31.00 ➝ $61.00
2/25/2025
Starbucks Co. stock logo
SBUX
Starbucks
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$115.00 ➝ $125.00
2/20/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$18.00 ➝ $21.00
2/19/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$38.00 ➝ $68.00
(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$1.48B5.12N/AN/A$1.61 per share21.12
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.29$4.03 per share6.38$15.81 per share1.63
Starbucks Co. stock logo
SBUX
Starbucks
$36.15B3.10$4.11 per share23.99($6.57) per share-15.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$23.55M$0.5477.2765.38N/A8.19%10.97%8.29%5/5/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4118.248.490.6412.62%19.47%8.09%4/29/2025 (Estimated)
Starbucks Co. stock logo
SBUX
Starbucks
$3.76B$3.1031.8426.963.599.73%-44.97%11.47%4/29/2025 (Estimated)

Latest HIMS, SBUX, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/24/2025Q4 2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.09$0.11+$0.02$0.11$494.56 million$481.14 million
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
1/28/2025Q1 2025
Starbucks Co. stock logo
SBUX
Starbucks
$0.68$0.69+$0.01$0.69$9.32 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.69%+2.50%121.99%16 Years
Starbucks Co. stock logo
SBUX
Starbucks
$2.442.47%+8.03%78.71%15 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/A
2.14
1.82
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73
Starbucks Co. stock logo
SBUX
Starbucks
N/A
0.75
0.57

Institutional Ownership

CompanyInstitutional Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Starbucks Co. stock logo
SBUX
Starbucks
72.29%

Insider Ownership

CompanyInsider Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
17.71%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Starbucks Co. stock logo
SBUX
Starbucks
0.09%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1,046222.17 million179.79 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable
Starbucks Co. stock logo
SBUX
Starbucks
402,0001.14 billion1.13 billionOptionable

Recent News About These Companies

Starbucks CEO outlines new "Back to Starbucks" business plan
Novo Nordisk, Starbucks shares slumping: Trending Tickers
Starbucks put volume heavy and directionally bearish
Starbucks Corp (SBUX) Trading Down 4.09% on Mar 10

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$34.00 -0.71 (-2.05%)
Closing price 03/12/2025 03:58 PM Eastern
Extended Trading
$34.42 +0.42 (+1.25%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Pfizer stock logo

Pfizer NYSE:PFE

$25.72 -0.27 (-1.02%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$25.76 +0.03 (+0.12%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Starbucks stock logo

Starbucks NASDAQ:SBUX

$98.69 -0.89 (-0.89%)
Closing price 03/12/2025 04:00 PM Eastern
Extended Trading
$98.68 -0.01 (-0.01%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks Coffee, Teavana, Seattle's Best Coffee, Ethos, Starbucks Reserve, and Princi brands. Starbucks Corporation was founded in 1971 and is based in Seattle, Washington.